ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia

Amir Hamzah Abdul Latiff; Salina Husain; Baharudin Abdullah; Palaniappan Suppiah; Vincent Tan; Tang Ing Ping; Kent Woo; Yoke Yeow Yap; Claus Bachert; Holger J. Schunemann; Anna Bedbrook; Wienczyslawa Czarlewski; Jean Bousquet

doi:10.3390/jpm13050835

ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia

Amir Hamzah Abdul Latiff
, Salina Husain
, Baharudin Abdullah
, Palaniappan Suppiah
, Vincent Tan
, Tang Ing Ping
, Kent Woo
, Yoke Yeow Yap
, Claus Bachert
, Holger J. Schunemann
, Anna Bedbrook
, Wienczyslawa Czarlewski
, Jean Bousquet

Department of Epidemiology and Environmental Health

Pantai Hospital Kuala Lumpur
Universiti Kebangsaan Malaysia
Universiti Sains Malaysia
Gleneagles Hospital Penang
KPJ Klang Specialist Hospital
Universiti Malaysia Sarawak
Kuala Lumpur Hospital
KPJ Johor Specialist Hospital
University of Münster
Sun Yat-Sen University
Ghent University
MASK-air
Medical Consulting Czarlewski
Charité – Universitätsmedizin Berlin
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
CHU Montpellier
University Paris-Sud

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

An increase in the prevalence of allergic rhinitis (AR) worldwide presents a significant burden to the health care system. An initiative was started in Europe designated as Allergic Rhinitis and Its Impact on Asthma (ARIA) to develop internationally applicable guidelines by utilising an evidence-based approach to address this crucial issue. The efforts are directed at empowerment of patients for self-management, the use of digital mobile technology to complement and personalise treatment, and establishment of real-life integrated care pathways (ICPs). This guideline includes aspects of patients’ and health care providers’ management and covers the main areas of treatment for AR. The model provides better real-life health care than the previous traditional models. This review summarises the ARIA next-generation guideline in the context of the Malaysian health care system.

Original language	English
Article number	835
Journal	Journal of Personalized Medicine
Volume	13
Issue number	5
DOIs	https://doi.org/10.3390/jpm13050835
State	Published - May 2023

Keywords

allergen immunotherapy
allergic rhinitis and its impact on asthma
antihistamines
clinical guidelines
integrated care pathways
intranasal corticosteroids

Access to Document

10.3390/jpm13050835

Cite this

Abdul Latiff, A. H., Husain, S., Abdullah, B., Suppiah, P., Tan, V., Ing Ping, T., Woo, K., Yap, Y. Y., Bachert, C., J. Schunemann, H., Bedbrook, A., Czarlewski, W., & Bousquet, J. (2023). ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia. Journal of Personalized Medicine, 13(5), Article 835. https://doi.org/10.3390/jpm13050835

@article{97aec7ff96504bf6a2d5c4d72a167beb,

title = "ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia",

abstract = "An increase in the prevalence of allergic rhinitis (AR) worldwide presents a significant burden to the health care system. An initiative was started in Europe designated as Allergic Rhinitis and Its Impact on Asthma (ARIA) to develop internationally applicable guidelines by utilising an evidence-based approach to address this crucial issue. The efforts are directed at empowerment of patients for self-management, the use of digital mobile technology to complement and personalise treatment, and establishment of real-life integrated care pathways (ICPs). This guideline includes aspects of patients{\textquoteright} and health care providers{\textquoteright} management and covers the main areas of treatment for AR. The model provides better real-life health care than the previous traditional models. This review summarises the ARIA next-generation guideline in the context of the Malaysian health care system.",

keywords = "allergen immunotherapy, allergic rhinitis and its impact on asthma, antihistamines, clinical guidelines, integrated care pathways, intranasal corticosteroids",

author = "\{Abdul Latiff\}, \{Amir Hamzah\} and Salina Husain and Baharudin Abdullah and Palaniappan Suppiah and Vincent Tan and \{Ing Ping\}, Tang and Kent Woo and Yap, \{Yoke Yeow\} and Claus Bachert and \{J. Schunemann\}, Holger and Anna Bedbrook and Wienczyslawa Czarlewski and Jean Bousquet",

note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = may,

doi = "10.3390/jpm13050835",

language = "English",

volume = "13",

journal = "Journal of Personalized Medicine",

issn = "2075-4426",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "5",

}

TY - JOUR

T1 - ARIA Care Pathways 2019

T2 - Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia

AU - Abdul Latiff, Amir Hamzah

AU - Husain, Salina

AU - Abdullah, Baharudin

AU - Suppiah, Palaniappan

AU - Tan, Vincent

AU - Ing Ping, Tang

AU - Woo, Kent

AU - Yap, Yoke Yeow

AU - Bachert, Claus

AU - J. Schunemann, Holger

AU - Bedbrook, Anna

AU - Czarlewski, Wienczyslawa

AU - Bousquet, Jean

PY - 2023/5

Y1 - 2023/5

N2 - An increase in the prevalence of allergic rhinitis (AR) worldwide presents a significant burden to the health care system. An initiative was started in Europe designated as Allergic Rhinitis and Its Impact on Asthma (ARIA) to develop internationally applicable guidelines by utilising an evidence-based approach to address this crucial issue. The efforts are directed at empowerment of patients for self-management, the use of digital mobile technology to complement and personalise treatment, and establishment of real-life integrated care pathways (ICPs). This guideline includes aspects of patients’ and health care providers’ management and covers the main areas of treatment for AR. The model provides better real-life health care than the previous traditional models. This review summarises the ARIA next-generation guideline in the context of the Malaysian health care system.

AB - An increase in the prevalence of allergic rhinitis (AR) worldwide presents a significant burden to the health care system. An initiative was started in Europe designated as Allergic Rhinitis and Its Impact on Asthma (ARIA) to develop internationally applicable guidelines by utilising an evidence-based approach to address this crucial issue. The efforts are directed at empowerment of patients for self-management, the use of digital mobile technology to complement and personalise treatment, and establishment of real-life integrated care pathways (ICPs). This guideline includes aspects of patients’ and health care providers’ management and covers the main areas of treatment for AR. The model provides better real-life health care than the previous traditional models. This review summarises the ARIA next-generation guideline in the context of the Malaysian health care system.

KW - allergen immunotherapy

KW - allergic rhinitis and its impact on asthma

KW - antihistamines

KW - clinical guidelines

KW - integrated care pathways

KW - intranasal corticosteroids

UR - https://www.scopus.com/pages/publications/85160342653

U2 - 10.3390/jpm13050835

DO - 10.3390/jpm13050835

M3 - Review article

AN - SCOPUS:85160342653

SN - 2075-4426

VL - 13

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

IS - 5

M1 - 835

ER -

ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this